MedTrace Logo

Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids

NCT02844920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2019-09-20

Study results available
· View outcomes & findings →

Summary

This study is designed to observe the presence or absence of intrauterine adhesions at 6 weeks after treatment with the Sonata® System through hysteroscopic evaluation by third party readers.

Conditions

  • Uterine Fibroids
  • Adhesions

Interventions

DEVICE

Intrauterine ultrasound guided radio-frequency ablation

Radiofrequency ablation for the treatment of uterine fibroids

Sponsors & Collaborators

  • Gynesonics

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-20
Primary Completion
2018-08-27
Completion
2018-08-27
FDA Device
Yes

Countries

  • Germany
  • Netherlands
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02844920 on ClinicalTrials.gov